• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

dapa

Anonymous

Guest
FDA endocrine agency not convinced at all on merits of dapa vs risks. This drug will never be able to compete. And remember how good BMS is with managed care. What do we need the specialty team for. To bring lunch I forgot
 

<